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Introduction

E
FFECTIVE ST RATEGIES TO CONTROL microvascular network growth me critical to improving the treatment of ischemic tissue diseases and to enhancing the regenerative capacity of implant materials. However, there is emerging recognition that capillary network expansion via angiogenesis often does not compensate for inadequate arteriolar blood flow to ischemic tissues, and that the growth of microvascular network..<; must be accompanied by vascular maturation and remodeling, whereby pericytcs and vascular smooth muscle ceUs (SMCs) are recruik-d to these nascent vessels.
l This latter process may also have been referred to as capillary arterialization/ arteriolar genesis/ or more broadly, arteriogenesis, the results of which being the new growth and structural enlargement of functional arterioles. 4 • s Thus, the ability to increase the number and diameter of resistance microvessels that are critical to improving blood flow must rely on a multitude of biological signals, including molecular regulators of arteriogencsis. Sphingosine I-phosphate (S1 P) is a bioactive sphingolipid that serves as a ligand for five known G protein-coupled receptors. It has been shown to stimulate endothelial cell (Ee) proliferation and migmtion 6 • 7 and to recnlit pericytes and SMC<; to immature vessels so that they may proliferate, migrate, and differentiate to a more contractile phenotype.8-1 1 Three of SIP's five receptors are expressed at high levels on ECs and SMCs: SI P l , S1P 2 , and SIP) (Fig. 1) . Importantly, these three receptors are coupled to different and opposing signaling cascades. SIP l is coupled specifically to G; proteins, 
Antagonist activity
' 511' 4 and 51 P s arc not found on BCs ,md 5MCs.
VaSC1llar-reiated effect s
Increases EC, SMC proliferation, and migration via SIP 1 (Kluk and Hla, 1O Lockman el al.
ll )
Inhibits SMC migration via SlP z (Saba and Hla J9 ) Stimulates 5MC differentiation to contractile phenotype via 51 P z (Lockman et al.
Inhibits VEGF-induced vascular penneability, mediates EC adherens junction formation, and increases EC survival
(Sanchez et al.;>5)
Enhances EC migration (Butler et al . .w) Decreases EC, 5MC proliferation at high doses (> \ ).1M) (Schmid eJ al?7) Increases neointimal hyperplasia (5MC proliferation) after acute balloon injury (VVamhoff et 11/.24 ) Increases EC, SMC migration (Osada et 111. 41 ) Improves diabetic wound healing (Kawanabc et al. 42 ) Increases 5MC proliferation, sUPEre5scs SIP-induced SMC differentiation (Wamhoff et al. 4) Enhances EC tube fonnation (Inoki el al. 43 ) Attenuates ncointimal hyperplasia (5MC proliferation) after acute balloon injury (VVamhoff et 111.24 ) Be endothelia! cell; 5MC, smooth mu~!e cell; 51 1' , sphingosine I-phosphate; VEGF, vascular endothdial growth factor. and both 511'2 and S1P3 are coupk>d to G;, G q , and G I2 proteins. 12 The activation of these different G proteins, including G; for proliferation, G n for cytoskeletal remodeling, and G'l for cellular effects, is elicited by 51P binding to its receptors on vascular cdls. \3·14 To this end, a general paradigm has emerged that 511\/511'3 signaling promotes 5MC proliferation and migration, whereas S1P2 has opposing actions. Activating andlor antagonizing specific combinations of these three SIP receptors on ECs and 5MCs may be an effl'Ctive strategy for promoting arteriogenesis in ischemic tissues by inducing 5MC proliferation and the growth of functional arteriolar microvessels (Table I) .
Effective in vivo models to monitor both temporal and spatial changes in microvascular growth and remodeling are critical in assessing the affL>cts of phannacological inducers of arteriogenesis. The dorsa l skinfold window chamber mooel has been established as an efficient model to track the temporal and spatial changes of vessels in the subcutant-'Ous microcirculation of mice. ls . 16 This model allows for intravital monitoring and quantitative assessment of changes occurring in the microvascular nehvork for several weeks. Further, the architecture of the window chamber is conducive to implantation of a variety of different dmg delivery systems and the stimulated tissue can easily be excised and examined with precise spatial reference to the implant using a variety of techniques (e.g., histology and immunohistochemistry).17 To study whole-network level microvascular remodeling in intact tissues, the spinotrapezius model has proven very useful in studying environmental factors in skeletal muscle while retaining spatial resolution. ' 8 , '9 The ability to expose the muscle to bolus injections or drug-releasing implants, to alter its local microenvironment, and to observe the changes in arterioles ill situ makes this model very useful for measuring arteriogenesis. The muscle can also be excised for more specific whole-motmt immimohistochemical analysis, preserving the spatial resolution of the vascular network.
In this work, we capitalize on the spa tio-temporal advantages of both the dorsal skinfold window chamber model and the spinotrapeziw; model in C57BI/fi mice to interrogate the roles of specific 5IP receptors in the microvascular environment Considering the establishment of 51 !' as a key signaling molecule in vascular ECsand SMCs during both development and adult wowid healing. and its demon<;tratcci effectiveness in ill vitro models of angiogenesis, there is surprisingly little known regarding its therapeutic potential for stimulating PLAGA control FTY720 619 whole-network level microvascular remodeling in vivo. To this end, analysis of 51!' receptor-specific signaling in the microvasculature is necessary if therapeutic strategies aimed at the induction of neovascularization are to be realized. In this work, we systematically evaluate the physiological responses of microvascular networks to varying patterns of 51 Preceptor targeting and activation at the tissue level. Activating and antagonizing differt-'I1t combinations of 51P TL'Ceptors atlows us to elucidate those receptors most critical for promotion of pharmacologically induced arteriogenesis. Our results demonstrate that 51P receptor-selective pharmacologic agents can be utilized to locally induce ncovasculari.z.1.tion and the formation of a mature vasculature, whidl has long-ranging implications in all areas of tissue repair and remodeling.
Materials and Methods
Materials
Poly(D, L-lactic-co-glycolic acid) (PLAGA) in a 50:50 formulation (71 kDa) was purchased from Lakeshore Biomater· ials. 51 P (379.5 Oa), PTY720 (307.5 Oa), and JTE013 (408.3 Oa) were purchased from Cayman Chemical. The prodmg compotutds VPC01091 (303.30a) and VPC44116 (451.3 Oa) were synthesized in the laboratories of Drs. Macdonald and Lynch at the University of Virginia.
Fabrication of PLAGA thin films
PLAGA thin polymeric films (1 mm diameter and 0.5 mm height) were cast tutlo..1.ded to be used as controls or loaded FIG. 2. 511'1,511\ activation with FfY720 enhances microvascular remodeling in window chamber. Intravital microscopy images of poly(D, L-lactic-co-glycolic acid) (PLAGA) films loaded with FTY720, VPC01091, 51 P+JTEOB, or 51P+ VPC441 16 in the dorsal skinfold window chamber at 0 and 7 days postimplantation of films. Substantial increases in new vascular growth are seen in response to FTY720. VPC01091, JTE013, and VPC44116 decrease funclionallength density over 7 days. Examples of vemiles are denoted by white arrows, and arterioles by bl,1Ck arrows. Blood. colwnn width is the diameter of the blood vessels as seen in intravital images and used to quantify changes in vessel diameter. Scale bar = 5OO).Im. Color images available online at www.1iebertonline.com/ten. Animal experiments were perfonllL>d using sterile techniques in accordance with an approved protocol from the University of Virginia Animal Care and Use Committee. Male C57Bl /6 mice (Harlan), age-matched (6) (7) (8) weeks) and weighing between 18 and 25g, were surgically fi lled with dorsal skinfold window chambers (APJ Trading Company, Inc.). After a waiting period of 7 days, control or drugloaded films were implanted into the window chamber (referred to as day 0) and imaged on days 3 and 7 post-
'"
Day 0",) implantation. For details, sec Sefcik et al. 1s and Wicghaus and coworkers. 1s
Ouantitative microvascular metrics
Intravi tal microscopy montages of entire vascular windows at days 0, 3, and 7 were analyzed using a combination of Adobe Photoshop CS and Image) (http://rsb.info.nih.gov/ij!) software. Blood vessels were analyzed within a circular region of interest (ROI) centered arOlmd the I-mm-diameter polymer film and extending 2 mm from the outer edge of the film (area of l~OJ is a circle of diameter 5 mm, or 19.6 mm 2 , St.'e Fig. 3 in Wieghaus and coworkers ls ). For microvascular length density measurements, vessels located within the ROI were traced using Photoshop and skeletonized using Image). These binary images were then analyzed by colmting the total number of black (vs. white) pixels, representing the total length of all traced vessels. Pixels were converted to mm using a micrometer and divided by the total area of the ROJ to yield length density. To assess changes in lumenal diameter, arteriole-venule pairs were identified within the ROls. In intravital images, vessels arc observed by blood colunm width, which is defined as the diameter of a perfused blood vessel as viewed under intravital microscopy in two dimensions. Therefore, arterioles and venules identified as a pair were labeled on day ° on the basis of size only-venule diameters
Effect of SIP receptor-selective activation on arteriolar (left) and venular (right) diameters after 3 (top) and 7 (bottom) d ays of treahnent with 1 mm PLAGA control films or PLAGA films loaded with SI P agonists and antagonists. Selective activation of 51P l and 511\ (with Ff'Y720 or 51P+JTE013) significillltl y increased both arte riolar illld venular diameters compared to 511' itself. Bars from left to right: PLACA, 511', FTY720, VPC0109l, 5IP+ JTE013, and 51P+ YPC44116. p<O.OS, relative to *PLAGA; ·51P;@YPC01091; sFTY720;ALL,allvenulegroups.
were larger than arteriolar diameters on day 0 (sec Fig. 2 for arrows distinguishing arterioles and venules on day 0). Identical vessel segments were labeled on days 0, 3, and 7 images at the bisection of each vessel segment in between branch points. Internal diameters based on blood column widths were measured using Image). The number of branch points was quantified by marking a point of bifurcation on a blood vessel at days 0, 3, and 7. This vessel branch was then followed and bifurcations were marked. Tht.'SC new branches were also tracked and marked at points of bifurcations; thus, branch points three degrees of freedom away from the parent vessel were quantified. The number of branch points at days 3 and 7 were normalized to the number present at day o. For lL'I1gth density, diameter, and branching metrics, the limit of resolution of vessels that can be observed is lO).Im; thus, capillaries «IO).Im) are not included in these analyses.
Tissue harvest and histological analysis of window chamber tissues
After the final imaging of the dorsal skinfold window chamber on day 7, mice were euthill1izcd for tissue harvest with an overdose of Nembutal administered intraperitoneally. Immediately, the chest cavity was opened and the vag... culature was perfused with lOmL of 1 xTris-buffered saline plus 0.1 mM CaCh and 2% hep arin via the right ventricle, followed by 10 mL of 1 xTris-buffered saline piLlS 0.1 mM CaCh and 10 mL 4% paraformaldchyde for vessel fixation. During this time, 4% paraformaJdchydc was dripped onto the exposed vascular region of the window chamber. After perfusion and fixation, the window chamber tissue was excised using surgical microscis..<;()rs. Tissues were embedded in paraffin, sectioned into 5-~lm-thick slices, and mOlmted onto glass slides by the University of Virginia Histology Core Facility. Paraffin sections were de-paraffinized and rehydrated using xylenes and a graded series of ethanol washes. IS Sections were washed in phosphate-buffered saline containing 0.1% saponin and 2% bovine sentm albumin (PBS/saponin/BSA) 3xlOmin each. Each tissue section was immunolabeled for smooth muscle Ct.-actin (SMA) using CY3-conjugated monoclonal anti-SMA (Sigma) diluted 1:500 in PBS/saponin/BSA and then mounted using a 50:50 solution of PBS and glycerol. Stained sections were imaged using a Nikon TE 2000-E2 confocal microscope equipped with a Melles Griot Argon Ion Laser System and Nikon D-Eclipse Cl accessories. Representative images were acquired using a 6Ox/1.45NA Nikon oil immersion objective and Nikon EZ-Ct software. The area of histological tissue sections was calculated by first outlining and then measuring the entire sections using ImageJ. The number of microvessels with obvious lumens staining positive for SMA were COlUlted under lO x magnification and then divided by the total sectional area. The limit of resolution for SMA+, an SMC marker, microvessels with an obvious lumen at lOxwas _6~lm, which could include capillaries.
Spinotrapezius surgical procedure
Male CS7Bl/fi mice (Harlan), age matched and weighing between 18 and 25g, were used for spinotrapezius surgeries. Mice were anesthetized via intraperitoneal injection of ketamine/xylazine/atropine (80/8/0.08mg/kg), shavL>d, and dL'Piiated. Surgical procedures detaik>d by Bailey et al.
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and Mac Gabhann illld Peirce 19 were modified to accompany PLAGA film implantation. A horse-shoc-shaped incision (-3-5 mm) was made through the dorsal skin, -Smm caudal to the bony prominence of the shoulder blade. Under a dissecting microscope, a characteristic kno t stnlCture of an artery-vein pair located at the caudal-lateral edge of the muscle was identified. The artery was traced up to the cranial end of the muscle, passing a classic loop structure, and evt.'I1tually leaving the muscle and traversing a fat pad. l he classic loop structure was used as a guide to mark the location to insert the polymer film. Above this location, the overlying fascia was blunt dissected to create a pocket a few millimeters in diameter. The 1 nun polymer film was then carefully placed into this pocket and the fascial layer was pulled back over top of the polymer. In this manner, the polymer stayed in place on top of the muscle. All implants were inserted into the right spinotrapezius muscle, with the left muscle serving as an internal control. The dors.1.1 skin incision was then dosed with 8-0 Ethilon sutures (Ethicon, inc.), illld the animal was allowed to rt.'Cover on a heating pad. Warmed Ringer's solution (37°C) with adenosine (1 mM), a potent vasodilator, was superfused onto the tissue throughout the smgery to aid in the observation of vessel architecture. Intravital images were taken during the s urgical procedure using an Olympus Microfire (Olympus) color digital camera.
Harvest and staining of whole-mount spinotrapezius tissues
On day 7 after polymer implantation, mice were euthanized and perfusion-fixed using methods described above. Both the left (untreated control) and right (treated) spinotrapezius muscles were stripped of the overlyi.ng fasci,l and excised. The polymer films were removed before staining to better observe the vasculature underneath the polymer. Tig... sues were washed in PBS/saponin /BSA 3xl0min each and then stained for SMA (lA4--Cy3; Sigma, 1 mg / mL) at room temperature for 1 h and then overnight at 4' C. The tis..<;ues were then washed with PBS, mOlUlted on glass slides using 50:50 PBS/glycerol, and imaged using confocal microscopy.
Statistical analyses
All statistical analyses were performed using Minitab 15 statistical software (Minitab, Inc.). Results are presented as mean ± standard error of the mean. Comparisons were made using a one-way analysis of variance, followed by Tukey's test for pairwise comparisons. Diameter analysis was performed using a General Linear Model analysis of variance with an unbalanced nested design, followL>d by Tukey's test for pairwise comparisons. Significance was assertL>d at p < 0.05.
Power calculations were performed with Ct. = 0.05 and power = 0.80 to determine statistically significant s.1.mple size.
Results
S1P" S1P 3 synergism enhances microvascular growth and remodeling
We hypothesized that by selectively activating the hvo receptors known to stimulate EC and SMC proliferation and migration (SIP 1 , SIP 3 ), both new vascular growth and vessel maturation would be significantly enhanced over time. To test this hypothesis, we delivered FrY720 (51 P1, 51 P3 agonist) in a controlled malUlcr from 1 nun thin films of PLAGA and assessed its ability to locally stimulate microvascular growth after a period of3 and 7 days in the window chamber. Previously, we reported on an unsteady state mass transport model to approximate the release kinetics of SIP from the polymer into the tissue space ([51 P] = 264 nM after 7 days at a distance of 1 mm away from the film). 15 Data from our lab using radiolabeled Xlp_SI P validated the model with SIP concentrations of ~5lXlnM in the tissue after 7 days within a distance of 1 mm from the film. Qualitative intravital microscopy images (Pig. 2) of ffi'72O-stimulated tissues show substantial increases in new microvesscl growth, which was confinned quantitatively by diameter and length density metrics, suggesting a release of rn720 from PLAGA in a concentra tion that stimulates cell proliferation and migration.
Treatment with FTY720 significantly increased the lumenal diameters of both arterioles and venules after 3 and 7 days compared to the unloaded PLAGA control or 511' itself (Fig. 3) . Diameter measurements were binned by initial diameter (diameter at d ay 0) as < 3O).1m for arterioles or < SO).1m for venules). A closer examination into the size range of arterioles undergoing lumenal expansion in response to FTY720 revealed that arterioles with the smallest range of initial diameters on day 0 «30 ~lm) wldenvent the most significant increase in diameter expansion compared to other size ranges. Additionally, FTY720 treatment significantly increased the diameter of the largest size arterioles (those binned > 50 11m at day 0) compared to PLAGA and 51P-treated tis.<;ues after 7 days, making it an attractive candidate for increasing local blood flow to ischemic tissues by enlarging the size of preexisting vessels (data not shown), Venular remodeling was similar to the trends observed in arterioles in response to FTY720 treatment. After 3 days of exposure to FfY72G-loaded films, venules significantly increased in blood column width, relative to unloaded controls (Fig. 3) . After 7 days of treatment, FfY720 elicited statistically si~,'nificant increases in venular diameter expansion compared to both control and 51P-treated tissues, As was the case with arterioles, venules in the smallest range of initial diameters «50 11m) underwent significant increases in diameter expansion compared to sub-50 11m venules in control or 51 Ptreated tissues after 3 and 7 days (data not shown).
Microvascular length density was also significantly increased after 3 and 7 days, relative to PLAGA-and 51P-treated tissues (Fig. 4) . Increased functional length density signifies an increase in the total length of blood vessels with blood column widths > lO).1m (in diameter). Thus, an increase in length density may occur by an increase in angiogenesis, by the sprouting of vessels from pre-existing vessels, or by a vascular maturation mechanism whereby existing capillaries «10 11m) recruit perivascular support cells and increase in size to point of visibility (> 10 ~lm) in the window chamber. To examine the angiogenic effect of FTY720, the number of branch points within the vascular networks was quantified. Results demonstrate a significant increase in the number of branch points in venu les after both 3 and 7 days of treatmL'llt with FTY720 compared to PLAGA control (Fig. 5) . Because angiogenic sprouts most often form from venules, it is not surprising that there is no significant difference in arteriolar branching between FTY720 and PLAGA To assess if the increase in length density from Fl'Y720 treatmL'llt was also a function of enhanced vascular matu-SEFCIK ET AL.
FIG . 4.
Effect of SIP receptor signaling modulation on functiona.l length density after 3 (gray bars) and 7 (black bars) days of treatment with 1 mm PLAGA control films or PLAGA films loaded with 51 P agonists and antagonists. 51 P 1 , 5HJ rse lective agonism with FTY720 significantly increased hmctional microvascular length density, Rars from left to right: PLAGA, 511', FrY720, VPCOl091, 51P+JTE013, and 51 P+ VPC44116. ~p < 0.05, significant to all other groups within respective time period (days 0-3, days 0-7). ration (increased 5MC coverage), dorsal skinfold window chamber tissue was harvested after 7 days and histologically sectioned and stained for SMA, a marker for 5MCs. FTY72G-treated tissues showed a significant increase in the numbers of 5MA positively stained microvcsscls (5MA+ ) compared to untreated controls (Fig. 6) . However, there was no statistical difference in SMA+microvessels per area between SlP-and FTY720-treated tissues.
Selective antagonism of S1P3 diminishes microvascular growth and remodeling mediated by S1P 1 , S1P 3 Local delivery of FTY720 to window chamber tissue significantly increased neovascularization and vessel maintenance over 7 days ill vivo compared to 51 P itself, suggesting that local activation of 511'1 and 511'3 acts synergistically to enhance EC and 5MC proliferation and migration. We next evaluated the individual contributions of both of these receptors by delivering VPC0109I, a 51P] agonist and 51 P 3 antagonist?O Local sustained release of VPCOl091 significantly decreased arteriolar diameters after 3 days in comparison to FfY72G-trcated tissues (Fig. 3) . Although this trend persisted after 7 days, comparison between VPC01091 and FfY720 was no longer significant. Release of VPCOI091 also significantly decreased the lumenal diameters of venules, compared to FTY720, after both 3 and 7 days of stimulation (Fig, 3) . There was no statistical difference in vCHular expansion between PLAGA-, 511'-, or VPCOl091-treated tissues.
There was a clearly observable decrease in vascular density over time with VPCOI091 treatment compared to PLAGA and FfY720 groups (Fig. 2) . Antagonism of 51P 3 via delivery of VPCOl091 resulted in a significant decrease in vascular length density (Fig. 4) at both days 3 and 7 compared to FlynO treatment. However, there was no statistical difference behVeen PLAGA-, SI P-, and VPCOI091 -treated tissues. VPC01091 treatment also significantly decreased the numbers of 5MA+ vessels per area compared to FTY720 treatment (Fig. 6) . Treatment with VPC01091 also appeared to result in fewer 5MA+ vessels per area compared to 5iP itself, although not statistically significant. Taken together, these results imply that 51 PJ51 P) receptor synergism by FTY720 elicits a more robust response than 51P] signaling alone (by VPC01091) in terms of vessel remodeling and overatl network maintenance.
Selective inhibition of S1P2 stimulates microvascular lumenal diameter expansion
FTY720 was shown to elicit robust microvascular remodeling responses. To support the hypothesis that 51 1'1 and 51P) act synergistically to enhance vascular density and increase diameters, we codelivered 511' with 51P z antagonist }TE013 and quanti fied the same remodeling metries in the dorsal skinfold window chamber. If synergistic activation of 511'1 and 511'3 are required for maximal increases in length density and diameter expansion and 511'2 is not involved, it is hypothesized that 51 P+JTE013 should mimic the actions of FrY720 and stimulate robust microvascular remodeling responses. Polymer fi lms containing 51 P and }TE013 were implanted into the window chamber and vascular metries were assessed after 3 and 7 days. Representative intravital images reveal a decrease in vascular density, but an apparent increase in venular blood column wid th (Fig. 2) . Quantitative evaluation of the vascular networks trealt.'Ci with 51 P+ JTE013 in fact revealed a significant increase in venular expansion af~ ter both 3 and 7 days, compared to all drug groups, including FTY720. This result could potentially be attributed to the difference in 511'2 signaling between coddivery of SIP and [TEOl3 and delivery of FYT720; ]TE013 is an antagonist at 5 JP2, whereas 51 1'2 remains available for signaling by endogenous 51 P during FTY720 treatment. Arteriolar diameters also exp,Ulded after both 3 and 7 days relative to PLAGA control, but with no statistical difference to fiY720 treatment (Fig. 3) .
Contradictory to lumenal expansion data, 511'+JTE013 significantl y decreased total functional length density of microvascular networks over time relative to FT'Y720 (Fig. 4) . After 7 days, there was no statistical difference in length density between control and 51P+}TE013-treated tissues. Taken together, these data examining the potential synergism of 511'1 and 511\ receptors via two different mechanisms (5lP+JTE013 vs. FrY720) highlight the complexity of both microvascular rL'lYlodeling and the role that 51 P receptorspecific signaling plays in this process. • p < 0.05, significant to FfY720. Color images available online at www .liebertonline.com I ten. Since 51 P I and 51 P J receptors appear to act synergistically to enhance microvascular remodeling in the dorsal skinfold window chamber, we hypothesized thai selectively inhibiting 511'1 and 51P3 signaling would thereby prevent microvascular growth and remodeling. VPC44116, a selective SIP] and SI P J an tagonist, was coencapsula ted with SI P and delivered to the window chamber. Microvascular metlies were assessed after 3 and 7 days of stimulation. As expected, the increase in venular diamcter in response to FTY720 and SlP+ JTE013 treatment after 3 and 7 d ays was reduced (Fig. 3) . Interestingly, this did not hold true for arterioles, as there was not a significant reduction in arteriolar diameter after 7 d ays compared to FTY720 or SIP+ JTE013 SEFCIK ET AL. * treatmen t. Figure 2 shows representative intravital images of the stark decrease in vascular density observed by SIP+VPC44116 treatment. Upon quantitative assessment, SlP+VPC44116 significantly reduct-'<I the increase in functionallength density resulting from FTY720 treatment. There was no statistical difference in length den.<;ity bern'eell PLAGA, 51 P, VPC01091, Of, most surprisingly, SI P+JTE013 treatmcnt.
Selective antagonism of S1P1 and S1P3 inhibits microvascular remodeling
-N • • • -• • • ---• • • • • • ill 0 so 70 .. ..
Effects of local sustained release of S1P receptor-targeted compounds in the spinotrapezius model
Although the dorsal skinfold window chamber model is an excelle nt tool to observe and quan tify precise changes in growt h and remodeling of the same microvascular networks over time, the remodeling responses of the subcutaneous microvasculature may differ from the response in skeletal muscle, a tissue that is classically used to assess arteriogenesis and remodeling in response to ischemia. 21 ,n The spinotrapezius muscles are a pair of skeletal muscles located on the dorsum adjacent to either side of the spine and running betwccn the fourth thoracic and third lumbar vertebrae in mice. The mouse spinotrapezius is well perfused with highly developed collateral vessels and arcade arteriole loops in C57Bl/6 mice, and is only 60-200 11m thick, thus allowing en face observation of the muscle tissue and microvascular networks. 18 . 19 To investigate if the effects of S1P-targeted compOlUlds on microvascular remodeling in the subcutaneous tissue (window chamber) are translatable to skeletal muscle, we delivered loaded polymer films to the spinotrapezius muscles of mice of the same strain and age and assessed changes in remodeling after 7 days.
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We hypothesized, based on window chamber resuits, that FTY720 treatment would increase arteriolar vascular b'TOwth and SMA coverage of microvessels of the spinotrapezius muscle. Preliminary investigation revealed that implantation of polymer films behvccn the fascia and the spinotrapezius muscle was successful, with minimal displacement in film location over time. Figure 7 shows representative intravital microscopy imagL"S 7 days postimplantation of FTY720-loaded PLAGA films in the spinotrapezius muscle (Fig. 7E ) and the overlying subcutaneous tissue (Fig. 7 A-D) . Qualitative inspection revealed that PTY720 stimulated an arteriogenic response, classified by classic signs of arteriogenesis, including increased tortuosity and collateralization of branching microvascular networks in both the skin and the muscle (Fig. 7 A, C,  E) . This increased tortuosity and collateralization was not observed in PLAGA·stimulated tissue (Fig. ?D, OJ . with SMA. The left muscle served as a contralateral control and received no implant (not shown). FTY720-stimulated arteriogenesis in the mouse spinotrapezius muscle (Fig. RB,  0) compared to PLAGA control (Fig. 8A, C) . The approximate area of tissue affe<:ted by film implantation is outlined by the white box in Fib'Ure SA and B, with magnified images shown in Figure SC and O. Classic signs of arteriogenesis]9 are seen in Figure 80 after treatment with FrY720, including collateral formation. Collaterals were not seen after treatment with PLAGA control polymer.
Discussion
We have previously reported that local, controlled release of SIP from biodegradable PLAGA consinlCts significantly enhanced the expansion of both arterioles and venules after 3 days of treatment in a murine dorsal skinfold window chamber model. This model is a useful tool for evaluating changes in microvascular remodeling because it allows for repeated measures and assessment of the same blood vessels over time to quantify growth and remodeling. The growth and structmal enlargement of local microvcssels was accompanied by a significant increase in BrdU-positive 5lvlA-staint. >d (5MA+ ) cells on the vessel wall, an observation suggestive of phannacologically induced arteriogencsis. 1s . 23 Although local sustained release of SIP from PLAGA films allowed for therapeutically relevant concentrations of 51 I' to be made available to the microvasculature for extended growth, early arteriogenic remodeling was diminished by 7 days postimplantation and the effects of SIP stimulation were no longer statistically significant. In this study, we investigated whether the use of appropriately engineered agonists and antagonists of 51 Preceptors could be utilized to enhance the results of SIP-induced growth and maintenance of microvascular networks.
Vascular SMCs are able to rapidly undergo phenotypic modulation from a contractile quiescent sta te expressing 5MC-specific differentiation genes (I.e., SMA, smooth muscle myosin heavy chain, SM22::t) to a highly synthetic proliferative and migratory phenotype.2 .. As a result of this unique characteristic, 5MCs playa critical role in blood vessel development, remodeling, and maintenance illld provide a therapeutic target for angiogenesis, atherosclerosis, and neointimal hyperplasia after vascular injury. In the latter case, our colleagues have demonstrated that acute balloon injury in the rat carotid artery leads to a significant increase in expression of 51 1'] and 51 P J recep tors and a significant decrease in 511'2 receptor expression on 5MCs up to 72h postinjury. Additionally, phannacological inhibition of 511'1 ,md 511'3 prevenlL>d SIP-induced 5MC proliferation and potentiated expression of genes that define the contractile phenotype.2s In the studies presented herein, phannacological stimulation of SIP] and 5IP J enhanced neovascularization and vessel maintenance, processes that require 5MC proliferation, suggesting a potential phenotypic switch to the synthetic phenotype. Thus, manipulating the phenotypic modulation of vascular 5MCs pharmacologically by strategically targeting known SIP receptor expression patterns could provide new avenues for growth of microvascular networks.
The major focus of these studies was to detennine if we could phannacologicaUy manipulate the 51 I' signaling axis to promote microvascular growth and maturation ill vivo. We used a library of SIP agonists and antagonists, namely, FIl720 (SIP], SIP), 51P4, 511'5 agonist), VPCOl091 (SIP], SIP .. , SIPs agonist, 511'3 antagonist), fTE013 (51 1'2 antagonist), and YPC44116 (511'1, 511'3 antagonist). Codclivery of SIP with JTE013 acted as a pharmacological agonist at 511'1, SIP J , 51P 4 , 511\ and antagonist at SlP2,. very similar to the actions of FTY720 but removing any potential contribution of 5 I 1'2 signaling. 51 I' delivered with VPC441 1 6 functioned as an 511'2,. 51 1'4, 51 1'5 agonist and 51 PI, 51 1'3 antagonist and served to elucidate the synergistic importance of 511'1 and 511 ' 3' l~esults from the dorsal skin fold window chamber model show that stimulation of both SIP 1 and 511'3 via delivery of agonist FIl720 enhances neovascularization and vessel maintenance; specifically, significant increases in lumenal diameter expansion, vascular length density, and 5MA+ vessels were observed in FrY72O-treatL>d tissues, compared to SIP and control samples. Additionally, r"l"Y720 stimulation significantly increased the number of branch points on venules compared to PLAGA alone. FlY720 is a prodmg requiring phosphorylation by sphingosine kinase into FfY72O-p, which is a potent agonist of SIl'l and S1P 3 on vascular ECs and SMCs. Signaling of FTY720-P through the SI PI receptor has ba'J1 shown ill vitro to elicit similar cellular functions as S1P, including cell migration and proliferation, among others?6 Our results ill vivo support FTY720-induced increases in cell migration and proliferation, as evidenced by increased length density, diameter, and branching on venules, a metric indicative of sprouting angiogenesis,J·27 In contrast, other studies have reported that FTY720 actually inhibits vascular endothelial growth factor~induced vascular permeability and angiogenesis.2S-30 The anti angiogenic effects of FfY720, though surprising based on its potent agonist activity, are proposed to occur as a result of functiona l antagonism. Although both SIP and FTY720 have been shown to internalize the S1 PI receptor into the endosomal pathway, FrY720 induces ubiquitinylation and proteosomal degradation of the receptor. 31 • 32 Therefore, the SIP] receptor, after being bound by FTY72O-P, is intema.lized and degraded, rendering it incapable of shuttling back to the cell surface for additional signaling. lnterestingly, S1P 3 receptors remain functiona l throughout FrY720 treatment, suggesting that SI P 3 may be compensating for SIP] to elicit significant increases in length den.<;ity and diameter expansion. 33 The contribution of S1I\ to vascular growth and maintenance was assessed using VPCOt091. [n contrast to FrY720 treatment, selective inhibition ofS11\ by VPC01091 resultL>d in a significant reduction of length density and diameter expansion, a<; well decrea'lCd munbers of 5MA+ves..<;eIs. Taken together, the results of FTY720 and VPC01091 highlight the importance of511\ in SIP-mediated microvascular remodeling and suggest that SIP I and StP 3 must be acting synergistically to enhance SMC proliferation and / or migration to a level greater than what is achievable by activation of SI PI alone.
To retain spatial relationships and to study struchlrally defined whole-mounted networks in intact tissues, we also examined the effects of local FTY720 delivery in the spinotrapezius skeletal muscle of mice. The spinotrapezius is a pre-<.-'Stablished model in an accessible tissue with a quick, minimally invasive surgery. Further, the spinotrapezius muscle is thin and flat, allowing whole nehvork-level observation of the microvasculature ell face using confocal microscopy. 18.19 FTY720 stimulated an arteriogenic response in the spinotrapezius muscle, classified by characteristic signs of arteriogem. "Sis, including increased tortuosity and collateralization of branching microvascular netv.'orks in both the skin and the muscle. 4 This increased tortuosity and collateralization were not obsen'ed in PLAGA-stimulated tissue. Our results with local FfY720 delivery show some remarkable similarities in the network-level remodeling to spinotrapezius muscles receiving an arteriolar ligation.] S Bailey et al. demonstrated arteriogenic remodeling in the spinotrapezius after ligation to a feeding arteriole in C57Bl/6 mice, marked by pronounced tOffilOSity, increased vascular density, increased branching, and collateral devdopmenl. 18 Additional investigation using this model could lead to a more complete understanding of the role of SlP I /51P 3 synergism in micro-627 vascular remodeling, as well as new strategies to induce arteriolar n. 'ffiodeling on a larger, network-level scale.
JTE013 is a specific antagonist of SI P 2 , activation of which has been shown to exert inhibitory effects on endothelial Rac activity, migration, and angiogenesis. 34 We hypothesized that by inhibiting 51 P z receptor signaling with J1'£013, while activating S1I'I and SlI\ Signaling with coadministration of SIP, we could induce and maintain a synthetic phenotype in microvascular SMCs. In fact, sustained release ofSI P+JTE013 significantly increased the diameter of arterioles and venules after 7 days compared to 51P treatment alone. Further, 511)+JT£013 treatment resulted in a significant expansion in venu]es relative to all comparative treatments, including FTY720. This discrepancy in arterial and VL'l10US TL"Sponses to the same compound could be explained by differences in receptor expression patterns behveen the two vessel types,35.36 but further validation is required. Unexpectedly, S1 P+JTE013 delivery did not significantly increase ftmctionallength density; in fact, length density significantly decreased over the course of 7 days compared to FIY720 treatment, although not statistically different than treatment with SIP alone. Taken together, this suggests that the mechanism of action for 51P+JTE013-induced changes in length density likely varies from that of FTY720 treatment. Studies have linked the activation of SlP3 by FTY720 to observations of enhanced neovascularization and bhxxl flow rL'Covery in ischemic hind limbs through a mechanism involving CXCR4 activation and SOF-1-induced homing of circulating (CD34+) progenitor cells. 37 Recmitment of trafficking progenitor cells in reSpo!1SC to FTY720 and their role in increasing microvascular growth and maintenance is currently being evaluated in our modeL Also notable, SI P+JTEOI3 responded similarly to 5tP+VPC44116 (SIP], StP) antagonist), which was hypothesized to significantly curtail FTY72O-induced increases in length density due to its selective inhibition at SIP] and SIP 3 . Our results with S1 P+VPC44116 demonstrated a significant reduction in both venular diameter expansion and length density, compared to treatment with FTY720, suggesting a diminution in SMC proliferation. Interestingly, however, 5tP+VPC44116 only moderately decreased arteriolar diameters in our model; we oosen'ed a 30% reduction in FTY720-increased arteriolar expansion compared to 140% reduction in venular expansion. These rL"Sults suggest that although similar mechanisms of action are attenuating FfY720-induced diameter expansion, differences in receptor expres..<;ion profiles on arterioles and venules may influence the magnitude of their respective responses. Also, 511'1 is active in the presence of StP+ VPC44116. S1 Pr inducL>d diminution of SMC proliferation is consistent with the published results of others, who showed that VPC44t16 significantly reduced neointimal hyperplasia (SMC proliferation) after acute balloon injury of the rat carotid artery?5 Selective activation of SI P 2 by 51 P likely results in 5MC phenotypic modulation to the contractile phenotype, with increaS<.-d expression of SMA or other SMC differentiation marker genes.
The results of this study demonstrate that selective activation of SIP] and SIP) synergistically promotes SIP-induced increases in ftmctionallength density, arteriolar and venular diameter expansion, and proliferation of SMA+cells. Additionally, our group fL'CL'J1tly reported that local, controlled release of FfY720 significantly increased new bone foonation, total microvcsscl density, and SMC i.nvestment on new vessels in a cranial bone defect modeL38 The local release of FIynO in a model of skeletal muscle also demonstrated r0-bust arteriolar remodeling in SMA+vessels at the wholenetwork level, highlighting a potentially new role for FTY720 in areas where increased tissue perfusion are required. Collectively, these studies suggest that activation of 51 P1 and SlP) with FfY720 in the microvasculature may prove to bean effective strategy for promoting therapeutic angiogenesis and arteriogencsis in regions of ischemia or tissue insult.
